Acutaas Chemicals — 360° view

Acutaas Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹437 crore and net profit of ₹123 crore for the September 2026 quarter.

Acutaas Chemicals (NSE: ACUTAAS) closed at ₹3,833.50 on 20 Nov 2026, up 121.3% over the past year. Its market capitalisation is ₹31,385 crore and it trades at 71.5 times earnings.

Share price
₹3,833.50 (20 Nov 2026)
Market cap
₹31,385 Cr (20 Nov 2026)
P/E
71.47 (20 Nov 2026)
Revenue
₹437 Cr (September 2026 quarter)
Net profit
₹123 Cr (September 2026 quarter)
ROCE
31.6% (FY26)
ROE
24.0% (FY26)
Book value
₹227 (FY26)
Dividend yield
0.07% (last 12 months to 20 Nov 2026)
52-week high / low
₹4,130.00 / ₹1,570.00 (20 Nov 2026)
1-year return
121.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ACUTAAS

Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.